Total planned funding: $844,342,448
Clear active filters
HTXD: Treatment: ARV Drugs
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Nigeria | $158,492,380 |
| Kenya | $125,883,573 |
| Tanzania | $106,869,193 |
| Uganda | $100,682,654 |
| Zambia | $96,055,673 |
| Mozambique | $62,845,877 |
| Zimbabwe | $41,989,486 |
| Côte d'Ivoire | $33,065,214 |
| Rwanda | $29,312,149 |
| Haiti | $23,029,579 |
| Vietnam | $22,008,275 |
| Democratic Republic of the Congo | $14,011,998 |
| Cameroon | $10,069,354 |
| Ukraine | $8,800,000 |
| Eswatini | $6,428,711 |
| South Sudan | $1,861,389 |
| Botswana | $1,483,167 |
| Burundi | $692,114 |
| Guyana | $500,000 |
| South Africa | $133,847 |
| Papua New Guinea | $57,440 |
| Central Asia Region | $26,020 |
| India | $23,477 |
| Malawi | $12,069 |
| Ethiopia | $8,809 |
Organizational Types
| Private Contractor | $686,219,282 |
| Host Country Government Agency | $92,700,001 |
| Unknown | $31,942,185 |
| NGO | $29,525,936 |
| Own Agency | $3,395,044 |
| University | $560,000 |
| FBO | $0 |
| Implementing Agency | $0 |
Program Areas
| Treatment | $844,342,448 |
Budget Codes
| HTXD: Treatment: ARV Drugs | $844,342,448 |
Top Partner Programs
Chemonics International:
$393,017,273
View countries
Kenya Medical Supplies Agency:
$92,700,001
View countries